0001892473-26-000010.txt : 20261023 0001892473-26-000010.hdr.sgml : 20261023 20261023125744 ACCESSION NUMBER: 0001892473-26-000010 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261023 DATE AS OF CHANGE: 20261023 EFFECTIVENESS DATE: 20261023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XRHealth, Inc. CENTRAL INDEX KEY: 0001892473 ORGANIZATION NAME: EIN: 853394158 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-602392 FILM NUMBER: 261481176 BUSINESS ADDRESS: STREET 1: 1330 BEACON ST STE 209 CITY: BROOKLINE STATE: MA ZIP: 02446 BUSINESS PHONE: 8579906111 MAIL ADDRESS: STREET 1: 1330 BEACON ST STE 209 CITY: BROOKLINE STATE: MA ZIP: 02446 D 1 primary_doc.xml X0708 D LIVE 0001892473 XRHealth, Inc. 300 1st Ave, Suite 103 Needham MA MASSACHUSETTS 02494 (857) 361-4594 DELAWARE None None Corporation true Eran Orr 157 Winthrop Road Brookline MA MASSACHUSETTS 02445 Executive Officer Director Founder & Chief Executive Officer Other Health Care Decline to Disclose 06b false 2026-10-22 false true false Series A-1 Preferred sold for cash to 17 investors, plus 121,910 shares to Connecticut Innovations, Inc. for debt relief; closed same day as, but under separate agreement from, the PursueCare/Harvest Bio MIPA stock consideration (reported separately). 0 3877693 3877693 0 273,611 shares of Series A-1 Preferred Stock at $14.1719/share: 151,701 shares sold for $2,150,000 cash (17 investors, per executed SPA Exhibit A), plus 121,910 shares to Connecticut Innovations, Inc. for debt relief. false 18 0 0 0 false XRHealth, Inc. Eran Orr Eran Orr CEO 2026-10-23